Developmental pluripotency-associated 4 increases aggressiveness of pituitary neuroendocrine tumors by enhancing cell

Shaista Chaudhary1, Ujjal Das1, Shaima Jabbar2,1

  • 1The Endocrine Program, Department of Animal Sciences, Rutgers, The State University of New Jersey, New Brunswick, New Jersey, USA.

Neuro-Oncology
|August 2, 2024
PubMed
Abstract

Insights

Developmental pluripotency-associated 4 (DPPA4) drives pituitary tumor stemness and aggressiveness by regulating WNT/β-CATENIN signaling. Targeting DPPA4 offers a potential therapeutic strategy for aggressive pituitary neuroendocrine tumors (PitNETs).

Area of Science:

  • Endocrinology
  • Cancer Biology
  • Molecular Oncology

Background:

  • Pituitary neuroendocrine tumors (PitNETs) are often aggressive and metastasize, with limited treatment options.
  • The molecular drivers of PitNET aggressiveness remain poorly understood.
  • Developmental pluripotency-associated 4 (DPPA4), a stem cell regulator, is overexpressed in some cancers but its role in PitNETs is unknown.

Purpose of the Study:

  • To investigate the role of DPPA4 in the aggressiveness of pituitary neuroendocrine tumors (PitNETs).
  • To elucidate the molecular mechanisms by which DPPA4 contributes to PitNET stemness and proliferation.

Main Methods:

  • Utilized both rat (prenatal-alcohol-exposed) and human pituitary tumor models.
  • Employed gene editing, ChIP assays, epigenetic studies, and receptor antagonism.
  • Assessed DPPA4 expression and its impact on cell proliferation, migration, and tumorigenic potential.

Main Results:

  • DPPA4 is overexpressed in aggressive PitNETs, correlating with increased cell stemness factors.
  • DPPA4 promotes PitNET cell proliferation, migration, and tumorigenesis by regulating WNT/β-CATENIN signaling.
  • Histone methyltransferase is involved in alcohol-induced activation of DPPA4.

Conclusions:

  • DPPA4 plays a significant role in pituitary tumor stemness and aggressiveness.
  • Targeting DPPA4 represents a potential therapeutic avenue for aggressive PitNETs.
  • Findings provide a preclinical basis for developing DPPA4-modulating therapies.

Related Concept Videos

Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
4.0K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Somatic to iPS Cell Reprogramming01:29

Somatic to iPS Cell Reprogramming

Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.2K
Maintenance of the ES Cell State01:14

Maintenance of the ES Cell State

The cells of the blastocyst inner cell mass only remain pluripotent for a short time. This state of pluripotency and self-renewal can be maintained in embryonic stem (ES) cell culture by adding specific chemicals or growth factors to ensure the cells can continue dividing and later differentiate into different cell types. In some cases, the cells are grown on a feeder layer of differentiated cells, which provides the growth factors and extracellular matrix components necessary for stem cell...
2.2K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.9K
Source And Potency Of Stem Cells01:27

Source And Potency Of Stem Cells

Stem cells are undifferentiated cells with extensive self-renewal properties that help them maintain their population during the fetal and adult stages of life. They can specialize in all cell types of the human body. However, their differential potential may vary and can be classified into five types. Stem cells can be (1) Totipotent, (2) Pluripotent, (3) Multipotent, (4) Oligopotent, and (5) Unipotent. Each stem cell has a specific origin; the fertilized egg or zygote is a totipotent cell and...
4.7K